3497.7000 -1.00 (-0.03%)
NSE May 28, 2025 15:31 PM
Volume: 1.2M
 

3497.70
-0.03%
Motilal Oswal
In 4QFY20, revenue (USD) / EBIT (INR)/PAT increased 1%/5%/-1% YoY (v/s TCS deal win TCV of USD8.9b (+44% YoY, ex-Phoenix deal) despite the COVID-19 shock during 4QFY20 was impressive. The pandemic is expected to pose continued near-term challenges on demand, supply, pricing and working capital fronts. The COVID-19 pandemic is expected to pose continued near-term challenges on demand, supply, pricing and working capital fronts. In 4QFY20, revenue (USD) / EBIT (INR)/PAT increased 1%/5%/-1% YoY (v/s our estimates of 3%/4%/-2% YoY). For FY20, revenue (USD) / EBIT (INR) / PAT grew BFSI saw sharp revenue decline (~4.8% QoQ, USD); we understand this is due to difficulty in securing approvals for work from home (WFM). Life Sciences and Healthcare (+3.3% QoQ, USD), Technology and Services (+0.9% QoQ, USD) and Communications (+0.2% QoQ, USD) remained outliers to the Despite an expected stretch on working capital cycle, the company increased its.
Tata Consultancy Services Ltd. is trading below its 100 day SMA of 3711.4
More from Tata Consultancy Services Ltd.
Recommended